文献速递结核与非结核分枝杆菌细菌感染、耐药与抗菌药物

贝达喹啉耐药结核病患者系列结核分枝杆菌分离株的基因型-表型特征

Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2024-01-01

研究对195例无既往贝达喹啉暴露的耐药结核病患者进行MGIT法贝达喹啉最低抑菌浓度检测,并对24例有分离株MIC>1者的系列分离株(共95株)行全基因组测序。24例中16例为贝达喹啉耐药(MIC≥4 µg/mL),8例为中间型(MIC=2 µg/mL),8例为多克隆感染,耐药涉及多种菌株类型和mmpR5突变,未发现atpE或pepQ突变,9对参与者共享遗传相似分离株(<5个单核苷酸多态性),提示可能存在传播性耐药。

要点

  • 24例中16例贝达喹啉耐药(MIC≥4 µg/mL),8例中间型(MIC=2 µg/mL)。
  • 8/24例为多克隆感染,耐药涉及多种菌株类型和mmpR5突变。
  • 9对参与者共享遗传相似分离株(<5个SNP),提示潜在传播性耐药。

核心结论

  • 贝达喹啉耐药结核可通过多种重叠过程产生,包括已有耐药菌株的传播。
  • 捕捉感染宿主体内多样性可能改善临床诊断、人群监测和分子诊断检测开发。

研究设计与样本

  • 对195例无既往贝达喹啉暴露且正在接受含贝达喹啉方案治疗的耐药结核病患者,检测结核分枝杆菌分离株的MGIT法贝达喹啉MIC。
  • 对24例在治疗前或治疗开始后有任何分离株贝达喹啉MIC>1的参与者,进行系列分离株全基因组测序,共95株分离株。

主要发现

  • 24例中16例为贝达喹啉耐药结核(MGIT MIC≥4 µg/mL),8例为贝达喹啉中间型感染(MGIT MIC=2 µg/mL)。
  • 治疗前已存在耐药者多于治疗期间获得耐药者,24例中8例为多克隆感染。
  • 贝达喹啉耐药见于多种结核分枝杆菌菌株类型,涉及多种mmpR5(Rv0678)突变,未发现atpE或pepQ突变。
  • 9对参与者共享遗传相似分离株(相隔<5个单核苷酸多态性),提示可能存在传播性贝达喹啉耐药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging resistance to bedaquiline (BDQ) threatens to undermine advances in the treatment of drug-resistant tuberculosis (DRTB). Characterizing serial Mycobacterium tuberculosis (Mtb) isolates collected during BDQ-based treatment can provide insights into the etiologies of BDQ resistance in this important group of DRTB patients. METHODS: We measured mycobacteria growth indicator tube (MGIT)-based BDQ minimum inhibitory concentrations (MICs) of Mtb isolates collected from 195 individuals with no prior BDQ exposure who were receiving BDQ-based treatment for DRTB. We conducted whole-genome sequencing on serial Mtb isolates from all participants who had any isolate with a BDQ MIC >1 collected before or after starting treatment (95 total Mtb isolates from 24 participants). RESULTS: Sixteen of 24 participants had BDQ-resistant TB (MGIT MIC ≥4 µg/mL) and 8 had BDQ-intermediate infections (MGIT MIC = 2 µg/mL). Participants with pre-existing resistance outnumbered those with resistance acquired during treatment, and 8 of 24 participants had polyclonal infections. BDQ resistance was observed across multiple Mtb strain types and involved a diverse catalog of mmpR5 (Rv0678) mutations, but no mutations in atpE or pepQ. Nine pairs of participants shared genetically similar isolates separated by <5 single nucleotide polymorphisms, concerning for potential transmitted BDQ resistance. CONCLUSIONS: BDQ-resistant TB can arise via multiple, overlapping processes, including transmission of strains with pre-existing resistance. Capturing the within-host diversity of these infections could potentially improve clinical diagnosis, population-level surveillance, and molecular diagnostic test development.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Brown TS, Tang L, Omar SV, et al. Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis. Clin Infect Dis. 2024. PMID: 37874928. doi:10.1093/cid/ciad596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。